Regeneron, listed on NASDAQ as REGN, is a prominent biotechnology company at the forefront of developing innovative medicines for patients facing various health challenges.
Utilizing the strength of scientific advancements, Regeneron is dedicated to creating new therapeutic solutions to address the unmet needs of individuals seeking improved treatment options.
Generated from their website's infomation